Q301--Intent to Sole Source Decipher Prostate Testing John D. Dingell VA Medical Center in Detroit, MI

SOL #: 36C25026Q0063Special NoticeSole Source

Overview

Buyer

Veterans Affairs

Veterans Affairs, Department Of

553-DETROIT (00553)

DETROIT, MI, 48201, United States

Place of Performance

Place of performance not available

NAICS

Medical Laboratories (621511)

PSC

Reference Laboratory Testing (Q301)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/37ad97e9ed8146bdbeb2290b494121c9/view

Timeline

Posted

Oct 16, 2025

Last Updated

Jun 2, 2026

Action Date

Oct 24, 2025, 4:00 PM

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the John D. Dingell VA Medical Center in Detroit, MI, has awarded a contract for Decipher Prostate Testing Services to VERACYTE LABS SD CORPORATION. The award, valued at $243,044.25, was made on June 2, 2026.

Scope of Work

The contract requires the contractor to provide all necessary supplies, labor, knowledge, techniques, supervision, test equipment, and analysis to perform specific Decipher Prostate Tests as requested by the medical center. These services fall under Product Service Code Q301 (Reference Laboratory Testing).

Contract Details

Contract Type: Firm Fixed Price
Awardee: VERACYTE LABS SD CORPORATION (UEI DKKCNLTYT2A1)
Award Amount: $243,044.25
Award Date: June 2, 2026
Period of Performance: One (1) year from contract award, with four (4) one-year options.
NAICS Code: 621511 (Medical Laboratories)
Size Standard: $41.5 million

Set-Aside & Justification

This was a sole-source award. The government's intent to negotiate with Veracyte Labs SD Corporation was based on FAR 13.106-1(b)(2), citing no responses to a previous sources sought posting and Veracyte Inc. being the sole provider of the patented and proprietary Decipher Prostate Cancer Classifier.